Literature DB >> 8843101

Intrastriatal taurine increases striatal extracellular dopamine in a tetrodotoxin-sensitive manner in rats.

M Ruotsalainen1, L Ahtee.   

Abstract

In vivo effects of locally administered taurine on striatal dopamine release and metabolism were studied by microdialysis in freely moving rats. Concentrations of dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) in striatal dialysates were quantified by high pressure liquid chromatography (HPLC) using electrochemical detection. Infusion of 150 mM taurine into the striatum for 2 h induced a 2.5-fold increase in the extracellular dopamine concentration. Extracellular DOPAC concentration increased nearly 2-fold. Taurine infusion initially decreased HVA to 70% but afterwards increased it to 140% of the control. When taurine was infused simultaneously with 1 microM tetrodotoxin starting 60 min after tetrodotoxin, the output of dopamine did not differ from that in the presence of tetrodotoxin alone. Tetrodotoxin abolished the effects of taurine on dopamine metabolites as well. Tetrodotoxin-sensitivity of the effects of taurine on dopamine and its metabolites suggests that intrastriatal taurine elevates extracellular dopamine by releasing it from neuronal pool.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8843101     DOI: 10.1016/0304-3940(96)12821-4

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  6 in total

1.  Effect of acute nicotine administration on striatal dopamine output and metabolism in rats kept at different ambient temperatures.

Authors:  T Seppä; M Ruotsalainen; I Laakso; R Tuominen; L Ahtee
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

2.  Taurine protects dopaminergic neurons in paraquat-induced Parkinson's disease mouse model through PI3K/Akt signaling pathways.

Authors:  Kaidong Wang; Baofu Zhang; Tian Tian; Bingyang Zhang; Ge Shi; Chunhui Zhang; Guoliang Li; Min Huang
Journal:  Amino Acids       Date:  2021-11-27       Impact factor: 3.520

3.  Long-lasting enhancement of corticostriatal transmission by taurine: role of dopamine and acetylcholine.

Authors:  A N Chepkova; O A Sergeeva; H L Haas
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

4.  The effects of systemically administered taurine and N-pivaloyltaurine on striatal extracellular dopamine and taurine in freely moving rats.

Authors:  J Salimäki; G Scriba; T P Piepponen; N Rautolahti; L Ahtee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-07-26       Impact factor: 3.000

5.  Taurine protects dopaminergic neurons in a mouse Parkinson's disease model through inhibition of microglial M1 polarization.

Authors:  Yuning Che; Liyan Hou; Fuqiang Sun; Cong Zhang; Xiaofang Liu; Fengyuan Piao; Dan Zhang; Huihua Li; Qingshan Wang
Journal:  Cell Death Dis       Date:  2018-04-01       Impact factor: 8.469

6.  Metabolic Profiling of CSF from People Suffering from Sporadic and LRRK2 Parkinson's Disease: A Pilot Study.

Authors:  Ali Yilmaz; Zafer Ugur; Ilyas Ustun; Sumeyya Akyol; Ray O Bahado-Singh; Michael Maddens; Jan O Aasly; Stewart F Graham
Journal:  Cells       Date:  2020-10-31       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.